Asia-Pacific Dermatology OTC Medications Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia-Pacific Dermatology OTC Medications Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia-Pacific Dermatology OTC Medications Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia-Pacific Dermatology OTC Medications Market Regional Analysis

6.2 Asia-Pacific Dermatology OTC Medications Market Revenue 2019-2028 (US$ Million)

6.3 Asia-Pacific Dermatology OTC Medications Market Forecast Analysis

7. Asia-Pacific Dermatology OTC Medications Market Analysis – by Product Type

7.1 Tablets and Capsules

7.1.1 Overview
7.1.2 Tablets and Capsules: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Gels

7.2.1 Overview
7.2.2 Gels: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Creams

7.3.1 Overview
7.3.2 Creams: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Ointments

7.4.1 Overview
7.4.2 Ointments: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia-Pacific Dermatology OTC Medications Market Analysis – by Route of Administration

8.1 Topical

8.1.1 Overview
8.1.2 Topical: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Oral

8.2.1 Overview
8.2.2 Oral: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia-Pacific Dermatology OTC Medications Market Analysis – by Indication

9.1 Dermatitis

9.1.1 Overview
9.1.2 Dermatitis: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Acne

9.2.1 Overview
9.2.2 Acne: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Psoriasis

9.3.1 Overview
9.3.2 Psoriasis: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Skin Bleaching

9.4.1 Overview
9.4.2 Skin Bleaching: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Fungal Disease

9.5.1 Overview
9.5.2 Fungal Disease: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.6 Warts

9.6.1 Overview
9.6.2 Warts: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Asia-Pacific Dermatology OTC Medications Market Analysis – by Distribution Channel

10.1 Online Distribution

10.1.1 Overview
10.1.2 Online Distribution: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Offline Distribution

10.2.1 Overview
10.2.2 Offline Distribution : Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Asia-Pacific Dermatology OTC Medications Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia-Pacific Dermatology OTC Medications Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 China: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.1.2 China: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.1.3 China: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.1.4 China: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Distribution Channel

11.2.1.2 India: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 India: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.2.2 India: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.2.3 India: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.2.4 India: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Distribution Channel

11.2.1.3 Japan: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Japan: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.3.2 Japan: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.3.3 Japan: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.3.4 Japan: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Distribution Channel

11.2.1.4 Australia: Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Australia: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.4.2 Australia: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.4.3 Australia: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.4.4 Australia: Asia-Pacific Dermatology OTC Medications Market Breakdown, by Distribution Channel

11.2.1.5 Rest of Asia-Pacific : Asia-Pacific Dermatology OTC Medications Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Dermatology OTC Medications Market Breakdown, by Product Type
11.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific Dermatology OTC Medications Market Breakdown, by Route of Administration
11.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific Dermatology OTC Medications Market Breakdown, by Indication
11.2.1.5.4 Rest of Asia-Pacific : Asia-Pacific Dermatology OTC Medications Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bausch Health Companies Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bayer AG

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Dr. Reddy's Laboratories

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Galderma

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 GlaxoSmithKline plc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Johnson and Johnson Services, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 LEO Pharma A/S

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Perrigo Company plc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Viatris Inc.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia-Pacific Dermatology OTC Medications Market